Trial intelligence / Profile preview

Tropicamide-Phenylephrine Combination for Pupil Dilation in Diabetic Patients

NCT07495670Completed

Sponsor
Burapha University
Start
Nov 2024
Primary completion
Jan 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of tropicamide and phenylephrine (4 arms), sponsored by Burapha University. Primary endpoint: Pupillary size at 30 minutes. Started Nov 2024; status: completed.

02

Drugs

tropicamidephenylephrine

Beyond the preview

Go deeper on NCT07495670.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07495670.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call